Literature DB >> 30656569

Outcomes in Super Obese Patients Undergoing One Anastomosis Gastric Bypass or Laparoscopic Sleeve Gastrectomy.

Vitish Singla1, Sandeep Aggarwal2, Bhanu Singh1, Gattu Tharun1, Varidh Katiyar1, Amit Bhambri1.   

Abstract

INTRODUCTION: The data on the role of OAGB in super obese patients and its direct comparison with LSG in super obese patients is scarce.
OBJECTIVES: To compare weight loss, impact on comorbidities and nutritional parameters between LSG and OAGB in super obese patients.
METHODS: Prospectively collected data of 75 matched patients with BMI > 50, who underwent either laparoscopic sleeve gastrectomy (LSG) or one anastomosis gastric bypass (OAGB), was analyzed retrospectively. Percentage excess weight loss at 1 year and impact on comorbidities were compared in both the groups.
RESULTS: Both the groups were comparable for age, sex, BMI, and presence or absence of diabetes mellitus. Mean TWL% ± 2SD at 1 year was 30.09% ± 19.76 in patients undergoing LSG, while it was 39.9% ± 12.78 in patients undergoing OAGB (p < 0.001). In the LSG group, 85.7% and 66.67% of patients had remission of diabetes mellitus and hypertension, respectively, as compared to 77.77% and 78.5%, respectively, in the OAGB group. All the patients with OSA had a resolution of their symptoms in both the groups. Patients in the OAGB group became more folate deficient despite regular supplementation.
CONCLUSION: Weight loss following OAGB was found to be better than LSG in the super obese patients in our study. There was a similar resolution of comorbidities and a lesser rate of major complications in the OAGB group.

Entities:  

Keywords:  One anastomosis gastric bypass; Outcomes; Sleeve gastrectomy; Super obese

Mesh:

Year:  2019        PMID: 30656569     DOI: 10.1007/s11695-018-03673-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  Criteria for definition of overweight in transition: background and recommendations for the United States.

Authors:  R J Kuczmarski; K M Flegal
Journal:  Am J Clin Nutr       Date:  2000-11       Impact factor: 7.045

2.  Body mass index is predictive of higher in-hospital mortality in patients undergoing laparoscopic gastric bypass but not laparoscopic sleeve gastrectomy or gastric banding.

Authors:  James Villamere; Alana Gebhart; Stephen Vu; Ninh T Nguyen
Journal:  Am Surg       Date:  2014-10       Impact factor: 0.688

3.  Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients.

Authors:  Robert Rutledge; Thomas R Walsh
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

4.  Management of super-super obese patients: comparison between one anastomosis (mini) gastric bypass and Roux-en-Y gastric bypass.

Authors:  Chetan Parmar; Mohamed A Abdelhalim; Kamal K Mahawar; Maureen Boyle; William R J Carr; Neil Jennings; Peter K Small
Journal:  Surg Endosc       Date:  2016-12-15       Impact factor: 4.584

5.  Long-Term Results of Laparoscopic Sleeve Gastrectomy for Morbid Obesity: 5 to 8-Year Results.

Authors:  Ralph P M Gadiot; L Ulas Biter; Stefanie van Mil; Hans F Zengerink; J Apers; Guido H H Mannaerts
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

6.  Laparoscopic bariatric surgery in super-obese patients (BMI>50) is safe and effective: a review of 332 patients.

Authors:  Manish S Parikh; Roy Shen; Matt Weiner; Niccole Siegel; Christine J Ren
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

7.  One thousand consecutive mini-gastric bypass: short- and long-term outcome.

Authors:  Roger Noun; Judith Skaff; Edward Riachi; Ronald Daher; Nayla Abi Antoun; Marwan Nasr
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

8.  Comparison of mini-gastric bypass with sleeve gastrectomy in a mainly super-obese patient group: first results.

Authors:  Andreas Plamper; Philipp Lingohr; Jennifer Nadal; Karl P Rheinwalt
Journal:  Surg Endosc       Date:  2016-07-21       Impact factor: 4.584

9.  Management of Super-super Obese Patients: Comparison Between Mini (One Anastomosis) Gastric Bypass and Sleeve Gastrectomy.

Authors:  Brijesh Madhok; Kamal K Mahawar; Maureen Boyle; William R J Carr; Neil Jennings; Norbert Schroeder; Shlok Balupuri; Peter K Small
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

10.  Laparoscopic mini-gastric bypass (LMGB) in the super-super obese: outcomes in 16 patients.

Authors:  Cesare Peraglie
Journal:  Obes Surg       Date:  2008-06-25       Impact factor: 4.129

View more
  10 in total

1.  One Anastomosis Gastric Bypass in Morbidly Obese Patients with BMI ≥ 50 kg/m2: a Systematic Review Comparing It with Roux-En-Y Gastric Bypass and Sleeve Gastrectomy.

Authors:  Chetan D Parmar; Catherine Bryant; Enrique Luque-de-Leon; Cesare Peraglie; Arun Prasad; Karl Rheinwalt; Mario Musella
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

2.  One anastomosis gastric bypass as a one-stage bariatric surgical procedure in patients with BMI ≥ 50 kg/m2.

Authors:  Mohammad Kermansaravi; Seyed Nooredin Daryabari; Reza Karami; Seyed Amin Setaredan; Rohollah Valizadeh; Samaneh Rokhgireh; Abdolreza Pazouki
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

3.  IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) Consensus Conference Statement on One-Anastomosis Gastric Bypass (OAGB-MGB): Results of a Modified Delphi Study.

Authors:  Almino C Ramos; Jean-Marc Chevallier; Kamal Mahawar; Wendy Brown; Lilian Kow; Kevin P White; Scott Shikora
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

4.  Clinical Outcomes of One Anastomosis Gastric Bypass Versus Sleeve Gastrectomy for Morbid Obesity.

Authors:  Chang Wu; Rixing Bai; Wenmao Yan; Ming Yan; Maomin Song
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

5.  Clinical outcomes after one anastomosis gastric bypass versus sleeve gastrectomy in super-super-obese patients.

Authors:  Karl Rheinwalt; Tom F Ulmer; Sophia M-T Schmitz; Patrick H Alizai; Andreas Kroh; Sandra Schipper; Jonathan F Brozat; Andreas Plamper; Ulf P Neumann
Journal:  Surg Endosc       Date:  2021-10-26       Impact factor: 3.453

6.  Laparoscopic Roux-En-Y gastric bypass versus one anastomosis (loop) gastric bypass for obesity: A prospective comparative study of weight loss and complications.

Authors:  Abdalla Mustafa; Nayer N H Rizkallah; Nehemiah Samuel; Shlokarth Balupuri
Journal:  Ann Med Surg (Lond)       Date:  2020-05-18

7.  Long-Term Trajectories in Weight and Health Outcomes Following Multidisciplinary Publicly Funded Bariatric Surgery in Patients with Clinically Severe Obesity (≥ 3 Associated Comorbidities): A Nine-Year Prospective Cohort Study in Australia.

Authors:  Michelle M C Tan; Xingzhong Jin; Craig Taylor; Adrian K Low; Philip Le Page; David Martin; Ang Li; David Joseph; Nic Kormas
Journal:  J Clin Med       Date:  2022-07-31       Impact factor: 4.964

8.  Outcomes and Effects of 250-cm Biliopancreatic Limb One Anastomosis Gastric Bypass in Patients with BMI > 50 kg/m2 with Total Bowel Length > 6 m: a 2-Year Follow-up.

Authors:  Moheb S Eskandaros
Journal:  Obes Surg       Date:  2022-04-29       Impact factor: 3.479

9.  The first survey addressing patients with BMI over 50: a survey of 789 bariatric surgeons.

Authors:  Mohammad Kermansaravi; Panagiotis Lainas; Shahab Shahabi Shahmiri; Wah Yang; Amirhossein Davarpanah Jazi; Ramon Vilallonga; Luciano Antozzi; Chetan Parmar; Radwan Kassir; Sonja Chiappetta; Lorea Zubiaga; Antonio Vitiello; Kamal Mahawar; Miguel Carbajo; Mario Musella; Scott Shikora
Journal:  Surg Endosc       Date:  2022-01-21       Impact factor: 3.453

10.  Is One Anastomosis Gastric Bypass with a Biliopancreatic Limb of 150 cm Effective in the Treatment of People with Severe Obesity with BMI > 50?

Authors:  Arnaud Liagre; Francesco Martini; Radwan Kassir; Gildas Juglard; Celine Hamid; Hubert Boudrie; Olivier Van Haverbeke; Laura Antolino; Tarek Debs; Niccolo Petrucciani
Journal:  Obes Surg       Date:  2021-06-26       Impact factor: 4.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.